Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Leptin Receptor Pipeline Drugs Market Report Overview
Leptin Receptor or LEP-R is a protein encoded by the LEPR gene. It acts as a receptor for the hormone LEP/leptin. Upon binding it mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade.
The Leptin Receptor pipeline drugs market research report provides comprehensive information on the Leptin Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Leptin Receptor targeted therapeutics development with respective active and dormant or discontinued projects.
Leptin Receptor Pipeline Drugs Market Segmentation by Therapy Areas
The key therapy areas in the Leptin Receptor pipeline drugs market are metabolic disorders, oncology, central nervous system, and non-malignant disorders. Metabolic disorders is the leading therapy area in the Leptin Receptor pipeline drugs market.
Leptin Receptor Pipeline Drugs Market Analysis by Therapy Areas
For more therapy area insights on the Leptin Receptor pipeline drugs market, download a free report sample
Leptin Receptor Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Leptin Receptor pipeline drugs market are Leptin Receptor Agonist and Leptin Receptor Antagonist. Leptin Receptor Agonist leads the pipeline market.
Leptin Receptor Pipeline Drugs Market Analysis, by Mechanisms of Action
For more MoA insights on the Leptin Receptor pipeline drugs market, download a free report sample
Leptin Receptor Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Leptin Receptor pipeline drugs market are subcutaneous, intravenous, and nasal. Subcutaneous is the most preferred RoA in the pipeline.
Leptin Receptor Pipeline Drugs Market Analysis, by Routes of Administration
For more RoA insights on the Leptin Receptor pipeline drugs market, download a free report sample
Leptin Receptor Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Leptin Receptor pipeline drugs market are recombinant protein, peptide, fusion protein, monoclonal antibody, oncolytic virus, recombinant peptide, and small molecule. Recombinant protein leads the pipeline market in terms of molecule types in 2022.
Leptin Receptor Pipeline Drugs Market Analysis, by Molecule Types
To know more about the molecule types in the Leptin Receptor pipeline drugs market, download a free report sample
Leptin Receptor Pipeline Drugs Market - Competitive Landscape
The leading companies in the Leptin Receptor pipeline drugs market are Amryt Pharma Plc, Aceragen Inc, Astellas Pharma Inc, Cellivery Therapeutics Inc, Jyant Technologies Inc, NeuroNano Pharma Inc, Neurotez Inc, and Regeneron Pharmaceuticals Inc. Amryt Pharma Plc dominated the market in 2022.
Leptin Receptor Pipeline Drugs Market Analysis, by Companies
To know more about the leading Leptin Receptor pipeline drugs market players, download a free report sample
Leptin Receptor Pipeline Drugs Market Report Overview
Key Therapy Areas | Metabolic Disorders, Oncology, Central Nervous System, and Non-Malignant Disorders |
Key Mechanisms of Action | Leptin Receptor Agonist and Leptin Receptor Antagonist |
Key Routes of Administration | Subcutaneous, Intravenous, and Nasal |
Key Molecule Types | Recombinant Protein, Peptide, Fusion Protein, Monoclonal Antibody, Oncolytic Virus, Recombinant Peptide, and Small Molecule |
Leading Companies | Aceragen Inc, Amryt Pharma Plc, Astellas Pharma Inc, Cellivery Therapeutics Inc, Jyant Technologies Inc, NeuroNano Pharma Inc, Neurotez Inc, and Regeneron Pharmaceuticals Inc |
Scope
- The report provides a snapshot of the global therapeutic landscape for Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR)
- The report reviews Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics and enlists all their major and minor projects
- The report assesses Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Amryt Pharma Plc
Astellas Pharma Inc
Cellivery Therapeutics Inc
Jyant Technologies Inc
NeuroNano Pharma Inc
Neurotez Inc
Regeneron Pharmaceuticals Inc
XL-protein GmbH
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Leptin Receptor pipeline drugs market?
The key therapy areas in the Leptin Receptor pipeline drugs market are metabolic disorders, oncology, central nervous system, and non-malignant disorders.
-
What are the key mechanisms of action in the Leptin Receptor pipeline drugs market?
The key mechanisms of action in the Leptin Receptor pipeline drugs market are Leptin Receptor Agonist and Leptin Receptor Antagonist.
-
What are the key routes of administration in the Leptin Receptor pipeline drugs market?
The key routes of administration in the Leptin Receptor pipeline drugs market are subcutaneous, intravenous, and nasal.
-
What are the key molecule types in the Leptin Receptor pipeline drugs market?
The key molecule types in the Leptin Receptor pipeline drugs market are recombinant protein, peptide, fusion protein, monoclonal antibody, oncolytic virus, recombinant peptide, and small molecule.
-
Which are the leading companies in the Leptin Receptor pipeline drugs market?
Some of the leading companies in the Leptin Receptor pipeline drugs market are Aceragen Inc, Amryt Pharma Plc, Astellas Pharma Inc, Cellivery Therapeutics Inc, Jyant Technologies Inc, NeuroNano Pharma Inc, Neurotez Inc, and Regeneron Pharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.